Analytical model to understand IP-driven commercial risks to an oncology portfolio
- What are the biggest IP-driven commercial risks to an oncology portfolio?
- Which risks are most sensitive to patent, exclusivity, targeted combination, formulation, & line extension assumptions?
What We Did
- We needed a platform to vary a number of assumptions to learn for ourselves what mattered vs. did not
- We decided to create a user-friendly Excel model that could handle many IP, commercial, & global assumptions
- We tested the model to confirm outputs worked as intended
- We then mined sensitivity scenarios for new insights
Our Results And Insight
- Interactive, user-friendly Excel model
- Dynamic timeline of IP protection
- New insights about IP and the portfolio
See other case studies
Service Areas Details
Commercial Strategy (Modeling, Intellectual Property)
Therapeutic Areas Details